MD3250G2 - Metodă de tratament al sindromului cheroto-conjunctivitei sica - Google Patents

Metodă de tratament al sindromului cheroto-conjunctivitei sica

Info

Publication number
MD3250G2
MD3250G2 MDA20060189A MD20060189A MD3250G2 MD 3250 G2 MD3250 G2 MD 3250G2 MD A20060189 A MDA20060189 A MD A20060189A MD 20060189 A MD20060189 A MD 20060189A MD 3250 G2 MD3250 G2 MD 3250G2
Authority
MD
Moldova
Prior art keywords
keratoconjunctivitis sicca
sicca syndrome
syndrome treatment
treatment
keratoconjunctivitis
Prior art date
Application number
MDA20060189A
Other languages
English (en)
Russian (ru)
Other versions
MD3250F1 (ro
Inventor
Мохаммад Абдулмаджед Х.
Владимир БОИШТЯНУ
Валериу РУДИК
Original Assignee
Мохаммад Абдулмаджед Х.
Владимир БОИШТЯНУ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мохаммад Абдулмаджед Х., Владимир БОИШТЯНУ filed Critical Мохаммад Абдулмаджед Х.
Priority to MDA20060189A priority Critical patent/MD3250G2/ro
Publication of MD3250F1 publication Critical patent/MD3250F1/ro
Publication of MD3250G2 publication Critical patent/MD3250G2/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la medicină, şi anume la oftalmologie şi este destinată tratamentului bolnavilor cu sindromul cheroto-conjunctivitei sica.Metoda, conform invenţiei, constă în aceea că în sacul conjunctival se instilează remediul BioR 0,5% câte 2 picături de 4…6 ori pe zi în decurs de 10…12 zile.
MDA20060189A 2006-07-14 2006-07-14 Metodă de tratament al sindromului cheroto-conjunctivitei sica MD3250G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20060189A MD3250G2 (ro) 2006-07-14 2006-07-14 Metodă de tratament al sindromului cheroto-conjunctivitei sica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20060189A MD3250G2 (ro) 2006-07-14 2006-07-14 Metodă de tratament al sindromului cheroto-conjunctivitei sica

Publications (2)

Publication Number Publication Date
MD3250F1 MD3250F1 (ro) 2007-02-28
MD3250G2 true MD3250G2 (ro) 2007-10-31

Family

ID=37845204

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20060189A MD3250G2 (ro) 2006-07-14 2006-07-14 Metodă de tratament al sindromului cheroto-conjunctivitei sica

Country Status (1)

Country Link
MD (1) MD3250G2 (ro)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2546922C1 (ru) * 2014-04-17 2015-04-10 Роман Валерьевич Калмыков Способ лечения синдрома "сухого глаза"

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2126669C1 (ru) * 1997-04-25 1999-02-27 Новокузнецкий государственный институт усовершенствования врачей Способ лечения синдрома сухого глаза

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2126669C1 (ru) * 1997-04-25 1999-02-27 Новокузнецкий государственный институт усовершенствования врачей Способ лечения синдрома сухого глаза

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Бржевский В.В., Сомов Е.Е. Роговично-конъюнктивальный ксероз (диагностика, клиника, лечение), Санкт-Петербург, 2003, с. 76-86 *

Also Published As

Publication number Publication date
MD3250F1 (ro) 2007-02-28

Similar Documents

Publication Publication Date Title
NZ606825A (en) Methods and compositions for treating complement-associated disorders
RU2010133480A (ru) Лечение метастатической стадии рака предстательной железы дегареликсом
PL1633368T3 (pl) Zdolne do tworzenia piany kompozycje farmaceutyczne i sposób leczenia zaburzenia
WO2008039218A3 (en) Inhibitors of bruton's tyrosine kinase
WO2008022256A3 (en) Methods and compositions for preventing or treating age-related diseases
MA30290B1 (fr) Therapie antitumorale a l'aide d'un anticorps contre le facteur de croissance endotheliale vasculaire et d'un anticorps contre le recepteur du facteur de croissance epitheliale humain de type 2
EP3530288A3 (en) Methods for treating conditions associated with masp-2 dependent complement activation
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
WO2008050329A3 (en) Novel sirnas and methods of use thereof
IL189546A0 (en) Therapy for the treatment of disease
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
WO2009020643A3 (en) Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue
WO2006002096A3 (en) Low doses of l-citrulline for treating diseases
ZA200810124B (en) Pharmaceutical combination comprising 3-(3-dimethyl-amino-1-ethyl-2-methyl-propyl)-phenol and Paracetamol
ATE284698T1 (de) Aktivierung natürlicher killerzellen durch adenosin-a3-rezeptoragonisten
MX2010009624A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1.
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
WO2021242844A8 (en) Grk2 inhibitors and uses thereof
MX2010004513A (es) Proceso de obtencion de un extracto estandarizado, extracto obtenido, composicion farmaceutica, metodo de tratamiento y uso de dicho extracto.
MD3250G2 (ro) Metodă de tratament al sindromului cheroto-conjunctivitei sica
ATE502637T1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
AU2021322255A8 (en) Use of dexpramipexole for the treatment of moderate to severe asthma
MX2022012001A (es) Tratamiento preventivo de la migra?a.
AU2020299145A8 (en) Compositions and methods for treating eye diseases
WO2004012677A3 (en) Methods and compositions to treat conditions associated with neovascularization

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees